Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

FOLFIRINOX is superior to gemcitabine in patients with pancreatic cancer, but this regimen is associated with toxicity and biomarkers for response are warranted. MicroRNAs can mediate drug resistance and could provide predictive information. Altered expressions of several microRNAs including miR-21-...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Future Sci OA
Hoofdauteurs: Schlick, Konstantin, Hohla, Florian, Hamacher, Frank, Hackl, Hubert, Hufnagl, Clemens, Markus, Steiner, Magnes, Teresa, Gampenrieder, Simon Peter, Melchardt, Thomas, Stättner, Stefan, Hauser-Kronberger, Cornelia, Greil, Richard, Rinnerthaler, Gabriel
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Future Science Ltd 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787156/
https://ncbi.nlm.nih.gov/pubmed/33437513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2020-0128
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items